About Ouyi Biomedical Technology
Ouyi Biomedical Technology is a Healthcare company based in Minhang (China) founded in 2009 by Jin Chao and Shi Xianjun. Provider of multi-omics testing services. Ouyi Biomedical Technology has raised $15.62 million across 2 funding rounds from investors including Dingshi Huize Investment Management, Orient Securities Capital and Sinopharm Capital. Its website oebiotech.com draws about 15 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Suite. Its competitors include Novogene Corporation and BGI; 1 of its 2 listed competitors has raised funding.
Company details
Ouyi Biomedical Technology was founded in 2009 in Minhang, China, within the biomedical sector. Multi-omics testing services are offered through a platform that covers nucleic acid, protein, and metabolism analysis. Technologies employed include single-cell sequencing, spatial multi-omics, protein and metabolic mass spectrometry, first- through third-generation sequencing, library preparation, and gene chip methods. Operations focus on comprehensive testing solutions for research applications.
- Headquarters Minhang, China
- Founders Jin Chao, Shi Xianjun
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oebiotech.com
- Total Equity Funding$15.62M (USD)
in 2 rounds
- Latest Funding Round$15.62M (USD), Series A
Nov 2021
- InvestorsDingshi Huize Investment Management
& 2 more
Funding Insights of Ouyi Biomedical Technology
Ouyi Biomedical Technology has successfully raised a total of $15.62M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.62 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.62M
- Total Rounds 2
- Last Round Series A — $15.62M
- Investors Count 3
All 2 funding rounds of Ouyi Biomedical Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $15.62M | Series A | – | Sinopharm Capital | |
| Aug 2021 | Series A | – | Orient Securities Capital |
3 investors in total: 3 institutional.
Investors in Ouyi Biomedical Technology
Ouyi Biomedical Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Dingshi Huize Investment Management, Orient Securities Capital and Sinopharm Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sinopharmcapital.com | ||||
Functions as an investment management firm specializing in financial assets. | 2018 | icapstone.com | Wuhan, China | |
Manages diversified investment portfolios across various asset classes. | 2010 | dfzt.com.cn | Huangpu, China |
Investor details for Ouyi Biomedical Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ouyi Biomedical Technology
5 people are tracked at Ouyi Biomedical Technology (5 in leadership).
| Name | Role | Group |
|---|---|---|
Dong Dong | Co-founder | Leadership |
Wang Shuwei | Co-founder | Leadership |
Jin Chao | Co-Founder | Leadership |
Xiao Yunping | Co-founder | Leadership |
Shi Xianjun | Co-Founder | Leadership |
Complete people profiles for Ouyi Biomedical Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ouyi Biomedical Technology
3 dated milestones of Ouyi Biomedical Technology across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Ouyi Biomedical Technology is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $15.6M.
Competitors of Ouyi Biomedical Technology
Ouyi Biomedical Technology has 2 listed competitors in our database, 1 of them funded. They include Novogene Corporation and BGI.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| bgi.com | 1999 | Shenzhen, China | 25 | BGI is engaged in genomics and precision medicine solutions. |
Detailed competitors of Ouyi Biomedical Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ouyi Biomedical Technology
The website of Ouyi Biomedical Technology (oebiotech.com) receives about 14.5K visits a month.
- Monthly visits14.5K
▼ 41.5% vs previous month
Websites whose visitors overlap most with Ouyi Biomedical Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wecomput.com | wecomput.com | 100% | #5,978,191 | – | |
| aptbiotech.com | 95% | 11.3K | #1,566,116 | View details | |
stomics.tech | stomics.tech | 94% | #1,480,696 | – | |
bio-info-trainee.com | bio-info-trainee.com | 93% | #2,803,754 | – | |
| bgitechsolutions.com | 93% | 4.5K | #4,220,961 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Ouyi Biomedical Technology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ouyi Biomedical Technology
Complete news archive for Ouyi Biomedical Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ouyi Biomedical Technology
Ouyi Biomedical Technology was founded in 2009 and raised its 1st funding round 12 years after it was founded.
Ouyi Biomedical Technology is headquartered in Minhang, China. It is registered at Minhang, Shanghai, China.
Ouyi Biomedical Technology is a funded company, having raised a total of $15.62M across 2 funding rounds to date.
Ouyi Biomedical Technology was founded in 2009 in Minhang, China, within the biomedical sector. Multi-omics testing services are offered through a platform that covers nucleic acid, protein, and metabolism analysis. Technologies employed include single-cell sequencing, spatial multi-omics, protein and metabolic mass spectrometry, first- through third-generation sequencing, library preparation, and gene chip methods. Operations focus on comprehensive testing solutions for research applications.
Ouyi Biomedical Technology's top competitors include Novogene Corporation and BGI.
Ouyi Biomedical Technology has 3 investors. Key investors include Dingshi Huize Investment Management, Orient Securities Capital, and Sinopharm Capital.